Inovio Pharmaceuticals (INO) Receivables - Other (2016 - 2023)
Historic Receivables - Other for Inovio Pharmaceuticals (INO) over the last 15 years, with Q1 2023 value amounting to $5.0 million.
- Inovio Pharmaceuticals' Receivables - Other rose 4228.96% to $5.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $5.0 million, marking a year-over-year increase of 4228.96%. This contributed to the annual value of $10.0 million for FY2022, which is 29125.66% up from last year.
- Per Inovio Pharmaceuticals' latest filing, its Receivables - Other stood at $5.0 million for Q1 2023, which was up 4228.96% from $10.0 million recorded in Q4 2022.
- In the past 5 years, Inovio Pharmaceuticals' Receivables - Other ranged from a high of $10.0 million in Q4 2022 and a low of $346974.0 during Q1 2021
- Moreover, its 5-year median value for Receivables - Other was $1.3 million (2019), whereas its average is $2.7 million.
- In the last 5 years, Inovio Pharmaceuticals' Receivables - Other plummeted by 6217.98% in 2020 and then skyrocketed by 90500.79% in 2022.
- Over the past 5 years, Inovio Pharmaceuticals' Receivables - Other (Quarter) stood at $1.3 million in 2019, then plummeted by 62.18% to $503782.0 in 2020, then skyrocketed by 409.19% to $2.6 million in 2021, then skyrocketed by 291.26% to $10.0 million in 2022, then plummeted by 50.56% to $5.0 million in 2023.
- Its last three reported values are $5.0 million in Q1 2023, $10.0 million for Q4 2022, and $7.6 million during Q3 2022.